Sfoglia per Autore
Microalbuminuria and hypertension.
2005 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi)
2007 Reboldi, Gianpaolo; Gentile, Giorgio
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke.
2008 Angeli, Fabio; Gentile, Giorgio; Reboldi, Gianpaolo; P., Verdecchia
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
2008 Reboldi, Gianpaolo; Angeli, Fabio; C., Cavallini; Gentile, Giorgio; G., Mancia; P., Verdecchia
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring.
2009 P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.
2009 P., Verdecchia; Angeli, Fabio; C., Cavallini; G., Mazzotta; S., Repaci; S., Pede; C., Borgioni; Gentile, Giorgio; Reboldi, Gianpaolo
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.
2009 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement.
2009 P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Comparative assessment of angiotensin receptor blockers in different clinical settings.
2009 P., Verdecchia; Angeli, Fabio; S., Repaci; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
2009 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia
Beta-blockers and risk of all-cause mortality in non-cardiac surgery.
2010 Angeli, Fabio; P., Verdecchia; G., Karthikeyan; G., Mazzotta; S., Repaci; M. d., Pinto; Gentile, Giorgio; C., Cavallini; Reboldi, Gianpaolo
Aliskiren versus ramipril in hypertension.
2010 P., Verdecchia; Angeli, Fabio; G., Mazzotta; P., Martire; M., Garofoli; Gentile, Giorgio; Reboldi, Gianpaolo
Optimal therapy in hypertensive subjects with diabetes mellitus
2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients
2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; Mancia, G; Verdecchia, P.
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.
2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Telmisartan for the reduction of cardiovascular morbidity and mortality.
2011 P., Verdecchia; Angeli, Fabio; Gentile, Giorgio; G., Mazzotta; Reboldi, Gianpaolo
Angiotensin-converting enzyme inhibitors
2012 Gentile, Giorgio; Reboldi, Gianpaolo; Angeli, Fabio; G., Mazzotta; P., Verdecchia
Blood pressure lowering in diabetic patients.
2012 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; G., Mancia; P., Verdecchia
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications
2012 P., Verdecchia; Angeli, Fabio; G., Mazzotta; M., Garofoli; E., Ramundo; Gentile, Giorgio; Ambrosio, Giuseppe; Reboldi, Gianpaolo
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes.
2012 Reboldi, Gianpaolo; Gentile, Giorgio; V. M., Manfreda; Angeli, Fabio; P., Verdecchia
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Microalbuminuria and hypertension. | 2005 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P. | |
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi) | 2007 | Reboldi, Gianpaolo; Gentile, Giorgio | |
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. | 2008 | Angeli, Fabio; Gentile, Giorgio; Reboldi, Gianpaolo; P., Verdecchia | |
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. | 2008 | Reboldi, Gianpaolo; Angeli, Fabio; C., Cavallini; Gentile, Giorgio; G., Mancia; P., Verdecchia | |
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. | 2009 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo | |
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. | 2009 | P., Verdecchia; Angeli, Fabio; C., Cavallini; G., Mazzotta; S., Repaci; S., Pede; C., Borgioni; Gentile, Giorgio; Reboldi, Gianpaolo | |
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. | 2009 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia | |
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. | 2009 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo | |
Comparative assessment of angiotensin receptor blockers in different clinical settings. | 2009 | P., Verdecchia; Angeli, Fabio; S., Repaci; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo | |
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. | 2009 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia | |
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. | 2010 | Angeli, Fabio; P., Verdecchia; G., Karthikeyan; G., Mazzotta; S., Repaci; M. d., Pinto; Gentile, Giorgio; C., Cavallini; Reboldi, Gianpaolo | |
Aliskiren versus ramipril in hypertension. | 2010 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; P., Martire; M., Garofoli; Gentile, Giorgio; Reboldi, Gianpaolo | |
Optimal therapy in hypertensive subjects with diabetes mellitus | 2011 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P. | |
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients | 2011 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; Mancia, G; Verdecchia, P. | |
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. | 2011 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P. | |
Telmisartan for the reduction of cardiovascular morbidity and mortality. | 2011 | P., Verdecchia; Angeli, Fabio; Gentile, Giorgio; G., Mazzotta; Reboldi, Gianpaolo | |
Angiotensin-converting enzyme inhibitors | 2012 | Gentile, Giorgio; Reboldi, Gianpaolo; Angeli, Fabio; G., Mazzotta; P., Verdecchia | |
Blood pressure lowering in diabetic patients. | 2012 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; G., Mancia; P., Verdecchia | |
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications | 2012 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; M., Garofoli; E., Ramundo; Gentile, Giorgio; Ambrosio, Giuseppe; Reboldi, Gianpaolo | |
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. | 2012 | Reboldi, Gianpaolo; Gentile, Giorgio; V. M., Manfreda; Angeli, Fabio; P., Verdecchia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile